Motor neuron disease and amyotrophic lateral sclerosis

Motor neuron disease and amyotrophic lateral sclerosis

In this post we’ll break down the major types of MNDs, compare their clinical features and highlight points crucial for competitive exams like NEET PG, INI-CET, and FMGE. Core issue is combination of UMN and LMN lesion findings coexistent in a same patient for ALS. Physicist Stephen hawking was the longest living survivor of this fatal disorder that ultimately causes demise due to diaphragmatic paralysis. As bonus tip learn differences between AIDP and CIDP in 2 minutes at the bottom of this article.

Comparison of Major Motor Neuron Disease 

Disease  UMN involvement  LMN involvement  Key features  Onset & Progression  Age of Onset  Prognosis 
Amyotrophic lateral Sclerosis (ALS) Mixed signs: spasticity + fasciculations; bulbar signs common Gradual onset, relentless progression 40-70 years Fatal within 3-5 years ( respiratory failure)
Primary Lateral Sclerosis  X Pure UMN signs: spasticity, hyperreflexia, Babinski sign: no fasciculations Very slow progression >50 years Relatively benign
Progressive muscular Atrophy (PMA) X Pure LMN signs; muscle wasting, fasciculations, flaccid weakness Gradual 30-60 years Better than ALS but can evolve into ALS
Spinal muscular Atrophy (SMA) X Symmetrical LMN weakness, hypotonia, tongue fasciculations (esp. in infants) Depends on type (infantile to adult) Infancy to adulthood Varies (SMA type I is fatal in infancy)
Progressive Bulbar Palsy  √ (bulbar UMNs) √ (bulbar LMNs) Dysarthria, dysphagia, tongue atrophy, emotional lability Often progresses to ALS 40-70 years Poor
Pseudobulbar Palsy  X Dysarthria, dysphagia, emotional lability, but no tongue wasting or fasciculations Often associated with bilateral stroked / MS Older adults Variable

 

Key Clinical Differences 

  1. ALS (Amyotrophic lateral sclerosis)
  • Hallmark: Combination of UMN and LMN signs in multiple regions
  • Buzzwords: Fasciculations + spasticity: tongue atrophy; split hand sign

  1. PLS (Primary Lateral Sclerosis) 
  • Hallmark: Pure UMN involvement
  • Clue: No Fasciculations or muscle wasting
  1. PMA ( Progressive Muscular Atrophy
  • Hallmark: Pure LMN disease
  • Buzzwords: Muscle atrophy, areflexia, fasciculations, no spasticity
  • May progress to ALS over time.
  1. SMA (Spinal Muscular Atrophy) 
  • Genetics: Autosomal recessive, SMN1 gene mutation
  • Types:
  • Type I (Werdnig-Hoffmann): Infantile, floppy baby, fatal in 1st year
  • Type II: Childhood onset
  • Type III: (Kugelberg-Welander): Adolescent / adult onset
  • Type: IV: Adult form, mildest

 

  1. Progressive Bulbar Palsy Vs Pseudobulbar Palsy 
  2. Feature  Progressive Bulbar  Pseudobulbar 
    Site CN IX – XII (LMN) UMN to bulbar nuclei
    Tongue Atrophy, fasciculations Small spastic, no atrophy
    Reflexes Absent gag reflex Exaggerated jaw jerk
    Emotional lability Present Present
    Association May be variant of ALS Often bilateral strokes /MS

     

    Important Exam Points 

    • Most common MND: ALS
    • ALS Affects both UMN and LMN – a key distinguishing feature
    • Fasciculations + spasticity: Think ALS
    • Tongue fasciculations in infants: Think SMA type I
    • No sensory involvement is typical in MNDs.
    • Frontotemporal dementia may coexist with ALS (especially C9 or F72 mutation)
    • Riluzole is the only FDA – approval drug for ALS – prolongs survival by ~3 months.

    Recent Advances 

    1. Risdiplam for SMA
    • Type: Oral SMN2 splicing modifier
    • Mechanism: Increases production of functional SMN protein via enhanced SMN2 splicing
    • Route: Oral syrup taken daily
    • Age: Approved for infants (>2 months), children, and adult
    1. Gene therapy for SMA (Type I) with nusinersen and onasemnogene abeparvovec has revolutionized prognosis in children.
    2. Edaravone has been added as a treatment option in some ALS cases.

     

    Bonus Tip 

    Comparison: AIDP vs CIDP

    Feature AIDP (Acute Inflammatory Demyelinating Polyradiculoneuropathy) CIDP (chronic Inflammatory Demyelinating Polyradiculoneuropathy) 
    Full form  Acute inflammatory demyelinating polyradiculoneuropathy Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    Type  Most common variant of GBS Chronic form
    Onset Acute (subtype of GBS) Chronic (≥ weeks)
    Progression  Rapid (Similar to GBS) Slowly progressive or relapsing
    Weakness Ascending symmetric Similar but slower, often proximal and distal
    Reflexes  Absent or decreased Absent or decreased
    CSF Same as GBS Same ( mildly elevated protein, low WBC)
    Nerve Conduction  Demyelinating Demyelinating
    Treatment  IVIG or plasmapheresis Steroids IVIG, plasmapheresis (long -term)

     

Leave a reply